(Cost-)effectiveness of an interdisciplinary head and neck rehabilitation program compared to usual supportive care for head and neck cancer patients

A prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22076

Enrollment

128

Registered

2018-04-04

Start date

2017-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer, quality of life, rehabilitation, return to work, societal participation Hoofd-halskanker, kwaliteit van leven, revalidatie, terugkeer naar werk, maatschappelijke participatie

Interventions

- Intervention group: Interdisciplinary head and neck rehabilitation program (IHNR) - Control group: Usual supportive care

Eligibility

Inclusion criteria

Inclusion criteria: - Patients (18 years or older) diagnosed with advanced head and neck squamous cell carcinoma (HNSCC; stage 3 and 4) - Patients are treated with primary chemoradiotherapy (Cisplatin or Carboplatin) or bioradiotherapy (Cetuximab) with curative intent

Exclusion criteria

Exclusion criteria: - Patients who are unwilling to cooperate - Patients who are unable to take part in the program due to a language barrier or an interfering psychiatric or psychological disorder are excluded from the study

Design outcomes

Primary

Measure	Time frame
- Health-related quality of life expressed in the EORTC QLQ-C30 summary score.	—

Secondary

Measure	Time frame
- Functional health-related quality of life - Cost-effectiveness - Return to work - Societal participation - Unmet needs of the patient - Patient satisfaction - Clinical outcomes (e.g. adverse events, hospital admissions)	—

Contacts

Public ContactA.C.C. Beck

a.beck@nki.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)